A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Clinical trial NCT06375993 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06375993
Sponsor: Adicet Therapeutics
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis Autoimmune Diseases Systemic Sclerosis (SSc)Systemic Lupus Erythematosus (SLE)ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathies Stiff Person Syndrome

Start date: 2024-11-10
Primary completion: 2026-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.